By Kaitlyn Snyder On November 19, 2024, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) issued a Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, extending the flexibilities through December 31, 2025.[1] The third—and supposedly final—temporary extension aims to give the DEA and HHS enough […]
